Nitracrine

This classification denotes an intercalating agent with the molecular formula C18H20N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 712MLZ30SB, chemically known as 1,3-propanediamine, n,n-dimethyl-n-(1-nitro-9-acridinyl)-, dihydrochloride but generally known as nitracrine, which bears US NIH Compound Identifier 20628. European Medicines Agency schedules Nitracrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09314MIG. The term NITRACRINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). NITRACRINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nitracrine under HS 29339990 and SITC 51577. As of Q4 2014, NITRACRINE remains the US FDA Preferred Term for this commodity. Nitracrine bears US NLM identifiers UMLS ID C0028120 and NCI Concept Code C694. SMILES: O[N](=O)c1c2c(NCCCN(C)C)c3c(nc2ccc1)cccc3.